Twitter | Search | |
Search Refresh
Philippe Aftimos, MD May 26
At , T. Karn and coll. from the GBG showed that TMB and immune GEP were independent predictive biomarkers of pCR in the neoadjuvant GeparNuevo trial for TNBC. The manuscript is now available in
Reply Retweet Like
VJ Oncology Jun 30
Reply Retweet Like
Icro Meattini May 24
Preventing cardiac damage is still more than relevant ⁩ ⁦
Reply Retweet Like
Nchic May 23
Proud to present the results from our study on gene expression profiling in SOLTI-1402/CORALLEEN trial ⤵️
Reply Retweet Like
Olga Martínez-Sáez May 23
I´m glad to share with you the results from our study regarding ctDNA dynamics in advanced breast cancer patients
Reply Retweet Like
Gil Morgan May 28
Just Out📣 Results of BROCADE3 in 🧬associated advanced breast cancer presented at sees ✅improvedPFS in patients with HR➕& in triple negative w/benefit of veliparib durable in both groups‼️
Reply Retweet Like
Elizabeth McKenna May 24
ICYMI in : Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Efficacy in
Reply Retweet Like
OncoAlert May 29
Dear Colleagues at A great pleasure to present our Amazing colleague who made a very important point last weekend at Regarding Fatigue in Patients. We need to Listen up! Best
Reply Retweet Like
Nature Medicine May 24
At , several sessions highlight the need for new for ― recent papers by Drs. Melero & Mariathasan identified IL-8 as measurable prognostic biomarker for patients treated with ICIs.
Reply Retweet Like
ESMO - Eur. Oncology May 25
: All presentations and webcasts from the ESMO Breast Cancer Virtual Meeting are now available to ESMO members on OncologyPRO, and with certain sessions available open access to all! 👉
Reply Retweet Like
Philippe Aftimos, MD May 26
Following the successful vritual, more great papers published in . Youc an find them here in the Articles in Press section:
Reply Retweet Like
MaitryCCPA May 23
Survivorship issues for young breast cancer survivors
Reply Retweet Like
Sherene Loi May 24
Presenting from at 2am. Though if I was in Berlin I’d be very jet lagged too by this time ⁦
Reply Retweet Like
MaitryCCPA May 23
Cancer patients have priorities other than cancer-free survival. It’s important to keep that in mind as oncology HCPs.
Reply Retweet Like
Neelima Denduluri May 23
Concise and complete algorithm to personalize therapy for hormone receptor positive breast cancer
Reply Retweet Like
Julia Maues May 23
Reminder: People living with metastatic cancer are survivors, too. Why are we excluded from most studies?
Reply Retweet Like
Gaia Griguolo May 23
I'm very glad to share with you our results regarding characterization of immune microenvironment before and following anti-HER2 neoadjuvant therapy in the SOLTI PAMELA trial!
Reply Retweet Like
pvukovic May 24
Current treatment algorithm of by dr. Reis-Filho
Reply Retweet Like
Aydah AlAwadhi May 23
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer
Reply Retweet Like
FabriceAndre May 23
For attendees to ; don t forget to have a look at the collection of breast cancer papers that prepared. the selection criteria was the number of readers in Q1 2020.
Reply Retweet Like